Ad
ALNY - Alnylam Pharmaceuticals Stock Trading
About | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Not available
Quote | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
| Last: | $169.175 |
|---|---|
| Change Percent: | 0.55% |
| Open: | $167.93 |
| Close: | $168.25 |
| High: | $169.765 |
| Low: | $166.02 |
| Volume: | 161,081 |
| Last Trade Date Time: | 12/01/2023 03:00:00 am |
News | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
-
2023-12-01 09:00:08 ET Summary Shares of Arrowhead Pharmaceuticals dropped this week after the company reported fiscal Q3 2023 results. Balance sheet concerns are weighing on the stock, and this is an urgent issue the company needs to address, and it has several options at its dis...
-
– Recognition Marks Alnylam’s Ninth Year in a Row on this Prestigious List, and the Third Consecutive Year Ranking #1 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its first-place ranking in Boston Globe’...
Message Board Posts | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $ALNY News Article - Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study | whytestocks | investorshangout | 09/13/2022 12:25:48 PM |
| whytestocks: $ALNY News Article - Alnylam Announces Pricing of Offering of $900 Million Convertible | whytestocks | investorshangout | 09/13/2022 12:20:47 PM |
| whytestocks: $ALNY News Article - Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study | whytestocks | investorshangout | 09/08/2022 4:15:54 PM |
| whytestocks: $ALNY News Article - Alnylam to Webcast Presentation at Morgan Stanley 20th Annual Glob | whytestocks | investorshangout | 09/06/2022 12:20:48 PM |
| whytestocks: $ALNY News Article - Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Bo | whytestocks | investorshangout | 08/24/2022 8:06:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Ad
-
– Recognition Marks Alnylam’s Ninth Year in a Row on this Prestigious List, and the Third Consecutive Year Ranking #1 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its first-place ranking in Boston Globe’...
-
2023-11-21 00:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
– Zilebesiran Met Primary Endpoint Demonstrating Up to 16.7 mmHg Placebo-Adjusted Reduction of 24-Hour Mean Systolic Blood Pressure at Three Months of Treatment – – Study Met Key Secondary Endpoints Showing Consistent and Sustained Reductions of Systolic Blood Pressur...